Loading organizations...
§ Venture Capital · 222 West 14th Street Suite 3L New York, NY 10011 United States
venture capital firm investing in seed and growth-stage companies, focused on the cannabis industry and related businesses.
Costa Verde Capital LLC operated as a venture capital firm, primarily focusing investments within the healthcare sector. The firm provided capital to emerging companies, supporting innovation and growth across various healthcare segments. Its strategic approach identified promising ventures advancing medical technologies, services, or patient care solutions.
Specific details regarding the founders and the firm's exact inception date are not publicly accessible. Costa Verde Capital LLC established itself in the investment landscape, likely driven by recognized opportunities within the specialized healthcare domain from its New York base. Its operational history suggests a commitment to this industry focus.
Costa Verde Capital LLC engaged with diverse healthcare companies, from early-stage to growth-phase enterprises. Its objective likely involved fostering critical advancements in healthcare, contributing to the broader medical innovation ecosystem. The firm's long-term vision was presumably achieving impactful outcomes through strategic capital deployment.
Costa Verde Capital has 1 tracked investment across 1 company. The latest tracked deal is $35.0M Debt / Series E in Auspex Pharmaceuticals in January 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 8, 2014 | Auspex Pharmaceuticals | $35.0M Debt / Series E | Jonathan Leff | Biomed Ventures, CMEA Capital, Oxford Finance, Panorama Capital, Thomas, McNerney & Partners |